Anzeige
Mehr »
Login
Dienstag, 30.04.2024 Börsentäglich über 12.000 News von 686 internationalen Medien
Basin Uranium: Es geht los! Der Uran-Superzyklus ist gestartet!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

PR Newswire-Archiv vom 09.12.2007

ZeitNachrichten
Sprache: Alle DE EN
LeserMedien
09.12.07Highest Reported Complete Remission Rate of 35 Percent Achieved in a Phase III Front-Line Multiple Myeloma Trial With Velcade(R) (Bortezomib) for Injection Based Therapy26ATLANTA, Dec. 9 /PRNewswire-FirstCall/ -- Millennium Pharmaceuticals, Inc. today announced the presentation of results from the 682 patient, randomized, Phase III VISTA(1) trial. These patients with...
► Artikel lesen
09.12.07Thalidomide Added to Standard Therapy Prolongs Overall Survival in Newly Diagnosed Multiple Myeloma Patients Over Age 7535ATLANTA, Dec. 9 /PRNewswire-FirstCall/ -- Pharmion Corporation today announced final data from a randomized, double-blind, placebo-controlled Phase 3 trial demonstrating that the addition of Thalidomide...
► Artikel lesen
09.12.07Photo: New Data Show Gleevec(R) Halts Progression to Advanced Stages of Life-Threatening Form of Leukemia in Sixth Year of Treatment377EAST HANOVER, N.J., Dec. 9 /PRNewswire-FirstCall/ -- New data from the largest clinical trial in newly diagnosed patients with a life-threatening form of leukemia showed that long-term use of Gleevec(R)...
► Artikel lesen
09.12.07Retail Holiday E-Commerce Spending Reaches $18 Billion for the Season, up 18 Percent Versus Year Ago11RESTON, Va., Dec. 9 /PRNewswire-FirstCall/ -- comScore, Inc. , a leader in measuring the digital world, today released an update of holiday season e-commerce spending for the first 37 days (November...
► Artikel lesen
09.12.07Nuvelo Phase 3 SONOMA-2 Trial Shows Alfimeprase has the Potential to Restore Catheter Function40SAN CARLOS, Calif., Dec. 9 /PRNewswire-FirstCall/ -- Nuvelo, Inc. today announced results from the Phase 3 SONOMA-2 (Speedy Opening of Non-functional and Occluded catheters with Mini-dose Alfimeprase-2)...
► Artikel lesen
09.12.07ATK Propulsion and Composite Technologies Help Launch COSMO Satellite19MINNEAPOLIS, Dec. 9 /PRNewswire-FirstCall/ -- Alliant Techsystems propulsion and composite technologies supported the successful launch of the United Launch Alliance's Delta II rocket procured by...
► Artikel lesen
09.12.07Pharmion Presents Clinical Data Demonstrating Significant Survival Advantage of Azacitidine (Vidaza(R)) in Patients With Myelodysplastic Syndromes (MDS)17ATLANTA, Georgia, December 9 /PRNewswire/ -- - Data Demonstrate 9.4 Month Median Overall Survival Benefit in Higher-risk MDS for Azacitidine Compared to Conventional Care Regimens (Log Rank...
► Artikel lesen
09.12.07Pharmion Presents Clinical Data Demonstrating Significant Survival Advantage of Vidaza(R) in Patients with Myelodysplastic Syndromes (MDS)17ATLANTA, Dec. 9 /PRNewswire-FirstCall/ -- Pharmion Corporation today announced complete results from a Phase 3 multi-center, international, randomized study of Vidaza(R) (azacitidine for injection)...
► Artikel lesen
09.12.07VRG Launches Flights to Santiago, Chile19SAO PAULO, Brazil, Dec. 9 /PRNewswire-FirstCall/ -- GOL Linhas Aereas Inteligentes S.A. , the parent company of Brazil's low-cost airlines GOL Transportes Aereos S.A. and VRG Linhas Aereas S.A., announces...
► Artikel lesen
09.12.07Sapiens Reports Payment of the Second Installment of the Principal of the Debentures19CARY, N.C., Dec. 9 /PRNewswire-FirstCall/ -- Sapiens International Corporation N.V. (Nasdaq and TASE: SPNS) a member of the Emblaze/Formula Group , announced today that it has paid the second installment...
► Artikel lesen